AU2002325467A8 - A immounlogical epitope of the hiv strain type o and the uses thereof - Google Patents

A immounlogical epitope of the hiv strain type o and the uses thereof

Info

Publication number
AU2002325467A8
AU2002325467A8 AU2002325467A AU2002325467A AU2002325467A8 AU 2002325467 A8 AU2002325467 A8 AU 2002325467A8 AU 2002325467 A AU2002325467 A AU 2002325467A AU 2002325467 A AU2002325467 A AU 2002325467A AU 2002325467 A8 AU2002325467 A8 AU 2002325467A8
Authority
AU
Australia
Prior art keywords
immounlogical
epitope
strain type
hiv strain
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002325467A
Other versions
AU2002325467A1 (en
Inventor
Xiaonan Dong
Yi Xiao
Yinghua Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING QINGDA YINGHUA BIO TEC
Tsinghua University
Original Assignee
BEIJING QINGDA YINGHUA BIO TEC
Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING QINGDA YINGHUA BIO TEC, Tsinghua University filed Critical BEIJING QINGDA YINGHUA BIO TEC
Publication of AU2002325467A8 publication Critical patent/AU2002325467A8/en
Publication of AU2002325467A1 publication Critical patent/AU2002325467A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002325467A 2002-07-29 2002-08-09 A immounlogical epitope of the hiv strain type o and the uses thereof Abandoned AU2002325467A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNA021253730A CN1472314A (en) 2002-07-29 2002-07-29 Immunity expression of AIDS virus O and its use
CN02125373.0 2002-07-29
PCT/CN2002/000552 WO2004011490A1 (en) 2002-07-29 2002-08-09 A immounlogical epitope of the hiv strain type o and the uses thereof

Publications (2)

Publication Number Publication Date
AU2002325467A8 true AU2002325467A8 (en) 2004-02-16
AU2002325467A1 AU2002325467A1 (en) 2004-02-16

Family

ID=30121235

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002325467A Abandoned AU2002325467A1 (en) 2002-07-29 2002-08-09 A immounlogical epitope of the hiv strain type o and the uses thereof

Country Status (3)

Country Link
CN (1) CN1472314A (en)
AU (1) AU2002325467A1 (en)
WO (1) WO2004011490A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
GB9005829D0 (en) * 1990-03-15 1990-05-09 Proteus Biotech Ltd Synthetic polypeptides
AU693098B2 (en) * 1993-06-09 1998-06-25 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides

Also Published As

Publication number Publication date
CN1472314A (en) 2004-02-04
WO2004011490A1 (en) 2004-02-05
AU2002325467A1 (en) 2004-02-16

Similar Documents

Publication Publication Date Title
USD513394S1 (en) Pendant
AU2003224725A1 (en) Hiv therapeutic
CA119397S (en) Bottle
HK1164694A1 (en) A personal care compound and product
USD506091S1 (en) Table
PL353560A1 (en) Fastening element in the form of a nail
IL160780A0 (en) USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
IL159090A0 (en) Soft bouillon tablet
TW511772U (en) Stroke-limited key structure and a keyboard including the key
AU2002245996A1 (en) Modified cyclosporine which can be used as a pro-drug and use thereof
AU2001268561A1 (en) 22109, a novel human thioredoxin family member and uses thereof
EP1548110A4 (en) Transglutaminase-producing strain
IL160782A0 (en) USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
AU2003232244A1 (en) Nanofiller, production, and use
AU2003298739A1 (en) Intermedin and its uses
AU2002325467A8 (en) A immounlogical epitope of the hiv strain type o and the uses thereof
AU2003301896A1 (en) Composite material and use of a composite material
USD469822S1 (en) Design craft kit construction component - rounded-point cross form
USD477125S1 (en) Isolation glove
GB0120316D0 (en) A method of forming a structure and a structure formed by the method
GB0200877D0 (en) A lightfitting and a method of packaging the same
USD479632S1 (en) Protective thumb covering
AU2003216688A1 (en) A device for transforming a lenear alternating modition into a working movement and uses for the device
GB0212221D0 (en) A cowdenser and cyclone employing the henley-mount J principle
KR100522448B1 (en) H I V HIV Like Particles And The Use Thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 12, PAGE(S) 3436 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME TSINGHUA UNIVERSITY, APPLICATION NO. 2002325467, UNDER INID (71) CORRECT THE NAME TO READ TSINGHUA UNIVERSITY; BEIJING QINGDA YINGHUA BIO-TECH CO., LTD.